| DNA damage repair in breast cancer and its therapeutic implications R Ali, EA Rakha, S Madhusudan, HE Bryant Pathology 49 (2), 156-165, 2017 | 63 | 2017 |
| Clinical impact of tumor DNA repair expression and T-cell infiltration in breast cancers AR Green, MA Aleskandarany, R Ali, EG Hodgson, S Atabani, ... Cancer immunology research 5 (4), 292-299, 2017 | 61 | 2017 |
| Internet of Things based smart hospital saline monitoring system P Nagaraj, V Muneeswaran, KM Sudar, RS Ali, AL Someshwara, ... 2021 5th International Conference on Computer, Communication and Signal …, 2021 | 40 | 2021 |
| Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma In Situ Induces Synthetic Lethality and Chemoprevention R Ali, A Al-Kawaz, MS Toss, AR Green, IM Miligy, KA Mesquita, ... Cancer Research 78 (24), 6818-6827, 2018 | 35 | 2018 |
| PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers R Ali, M Alabdullah, A Alblihy, I Miligy, KA Mesquita, SYT Chan, ... Cancer Letters 469, 124-133, 2020 | 32 | 2020 |
| Can cisplatin therapy be improved? Pathways that can be targeted R Ali, M Aouida, A Alhaj Sulaiman, S Madhusudan, D Ramotar International Journal of Molecular Sciences 23 (13), 7241, 2022 | 26 | 2022 |
| Targeting ataxia telangiectasia-mutated-and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy N Al-Subhi, R Ali, T Abdel-Fatah, PM Moseley, SYT Chan, AR Green, ... Breast Cancer Research and Treatment 169, 277-286, 2018 | 24 | 2018 |
| Flexible bolus insulin intelligent recommender system for diabetes mellitus using mutated kalman filtering techniques P Nagaraj, V Muneeswaran, R Sabik Ali, T Sangeeth Kumar, ... Congress on Intelligent Systems: Proceedings of CIS 2020, Volume 2, 565-574, 2021 | 21 | 2021 |
| Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers R Ali, A Alblihy, IM Miligy, ML Alabdullah, M Alsaleem, MS Toss, ... Oncogene 40 (14), 2496-2508, 2021 | 20 | 2021 |
| Clinicopathological and functional significance of RECQL1 helicase in sporadic breast cancers A Arora, S Parvathaneni, MA Aleskandarany, D Agarwal, R Ali, ... Molecular cancer therapeutics 16 (1), 239-250, 2017 | 17 | 2017 |
| Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers R Ali, M Alabdullah, M Algethami, A Alblihy, I Miligy, A Shoqafi, ... Theranostics 11 (17), 8350, 2021 | 16 | 2021 |
| The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response G Barone, A Arora, A Ganesh, T Abdel-Fatah, P Moseley, R Ali, SYT Chan, ... Oncotarget 9 (50), 29508, 2018 | 16 | 2018 |
| Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape MA Glaire, NAJ Ryan, ME Ijsselsteijn, K Kedzierska, S Obolenski, R Ali, ... The Journal of pathology 257 (3), 340-351, 2022 | 14 | 2022 |
| FEN1 blockade for platinum chemo-sensitization and synthetic lethality in epithelial ovarian cancers KA Mesquita, R Ali, R Doherty, MS Toss, I Miligy, A Alblihy, D Dorjsuren, ... Cancers 13 (8), 1866, 2021 | 14 | 2021 |
| XRCC1 deficient triple negative breast cancers are sensitive to ATR, ATM and Wee1 inhibitor either alone or in combination with olaparib R Ali, A Alblihy, MS Toss, M Algethami, R Al Sunni, AR Green, EA Rakha, ... Therapeutic Advances in Medical Oncology 12, 1758835920974201, 2020 | 13 | 2020 |
| ATM regulated PTEN degradation is XIAP E3 ubiquitin ligase mediated in p85α deficient cancer cells and influence platinum sensitivity R Ali, M Alabdullah, I Miligy, M Normatova, R Babaei-Jadidi, A S. Nateri, ... Cells 8 (10), 1271, 2019 | 12 | 2019 |
| Clinicopathological significance of ataxia telangiectasia-mutated (ATM) kinase and ataxia telangiectasia-mutated and Rad3-related (ATR) kinase in MYC overexpressed breast cancers C Savva, K De Souza, R Ali, EA Rakha, AR Green, S Madhusudan Breast Cancer Research and Treatment 175, 105-115, 2019 | 11 | 2019 |
| ERCC1 is a predictor of anthracycline resistance and taxane sensitivity in early stage or locally advanced breast cancers TMA Abdel-Fatah, R Ali, M Sadiq, PM Moseley, KA Mesquita, G Ball, ... Cancers 11 (8), 1149, 2019 | 10 | 2019 |
| Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers A Alblihy, R Ali, M Algethami, A Shoqafi, MS Toss, J Brownlie, NJ Tatum, ... NPJ precision oncology 6 (1), 51, 2022 | 9 | 2022 |
| Clinical impact of tumor DNA repair expression and t-cell infiltration in breast cancers. Cancer Immunol. Res. 2017; 5: 292–299. doi: 10.1158/2326-6066 AR Green, MA Aleskandarany, R Ali, EG Hodgson, S Atabani, ... CIR-16-0195.[Abstract][CrossRef][Google Scholar], 0 | 9 | |
